Provided by Tiger Trade Technology Pte. Ltd.

Intensity Therapeutics, Inc.

4.74
-0.1200-2.47%
Volume:15.70K
Turnover:73.14K
Market Cap:15.48M
PE:-0.99
High:4.84
Open:4.57
Low:4.57
Close:4.86
52wk High:43.50
52wk Low:3.51
Shares:3.26M
Float Shares:3.04M
Volume Ratio:1.11
T/O Rate:0.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.8026
EPS(LYR):-8.5567
ROE:-195.88%
ROA:-89.91%
PB:1.68
PE(LYR):-0.55

Loading ...

Aug 12, 2025

Major Issues Report

Form 8-K - Current report
Aug 08, 2025

Major Issues Report

Form 8-K - Current report
Aug 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2025

Major Issues Report

Form 8-K - Current report
Jul 18, 2025

Major Issues Report

Form 8-K - Current report
Jun 27, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 13, 2025

Major Issues Report

Form 8-K - Current report
Jun 12, 2025

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jun 06, 2025

Major Issues Report

Form 8-K - Current report
May 21, 2025

Major Issues Report

Form 8-K - Current report
May 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2025

Major Issues Report

Form 8-K - Current report
Apr 25, 2025

Major Issues Report

Form 8-K - Current report
Apr 24, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 23, 2025

Major Issues Report

Form 8-K - Current report
Apr 23, 2025

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Apr 23, 2025

Correspondence

Form CORRESP - Correspondence
Apr 22, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Mar 13, 2025

Major Issues Report

Form 8-K - Current report
Mar 13, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]